medindia
  1. Medindia
  2. Health Tips and Quotations

FDA Approved Brigatinib Drug For Lung Cancer Treatment

Cancers caused due to the abnormal proliferation of the cells in the lungs are referred to as Lung cancer. Around 3-5% of lung cancers are caused due to the changes in gene Anaplastic lymphoma kinase (ALK). Brigatinib drug receives approval from FDA to treat ALK-positive lung cancer as second-line therapy.

Brigatinib Drug: Next generation ALK inhibitor to treat lung cancer - Anaplastic lymphoma kinase (ALK) gene changes could cause lung cancer - Brigatinib drug has been approved by the FDA as second-line therapy for lung cancer treatment

FDA Approves Brigatinib Drug For ALK-Positive Lung Cancer Treatment

Brigatinib drug is a next generation Anaplastic lymphoma kinase (ALK) inhibitor that receives FDA approval as a second-line therapy for lung cancer treatment. Read More

Related Links

Slim Down Naturally With Ash Gourd Juice
Do You Get Drowsy At Work After Having Lunch?
Eating Right at Night: Choosing the Best Foods for Evening Health
Menopause and Heart Health: Protecting Your Cardiovascular Wellness
Savor Strawberries Everyday to Keep Dementia at Bay
High-Protein Breakfast: Your Path to Body Fat Loss
Why Does Foot Swelling Occur While Flying?
Mood Foods: What to Eat and What to Avoid for Better Mental Health
Men's Health Signals You Should Not Ignore
Top 5 Everyday Habits That Affect Your Vision
Harness the Healing Power of Avocado Seed Tea
Nutritional Guide to Staying Healthy During the Monsoon Season

Wildcard SSL

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer

Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2024